Literature DB >> 28168418

[Acetabular revision arthroplasty : Current concepts and new developments].

B M Holzapfel1, M Rudert2.   

Abstract

Mesh:

Year:  2017        PMID: 28168418     DOI: 10.1007/s00132-016-3374-2

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


× No keyword cloud information.
  6 in total

1.  The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset.

Authors:  A Patel; G Pavlou; R E Mújica-Mota; A D Toms
Journal:  Bone Joint J       Date:  2015-08       Impact factor: 5.082

2.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.

Authors:  Steven Kurtz; Kevin Ong; Edmund Lau; Fionna Mowat; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2007-04       Impact factor: 5.284

3.  Primary and revision arthroplasty surgery caseloads in the United States from 1990 to 2004.

Authors:  Steven M Kurtz; Kevin L Ong; Jordana Schmier; Ke Zhao; Fionna Mowat; Edmund Lau
Journal:  J Arthroplasty       Date:  2008-04-15       Impact factor: 4.757

4.  Hip and knee replacement in Germany and the USA: analysis of individual inpatient data from German and US hospitals for the years 2005 to 2011.

Authors:  Annelene Wengler; Ulrike Nimptsch; Thomas Mansky
Journal:  Dtsch Arztebl Int       Date:  2014-06-09       Impact factor: 5.594

5.  Prevalence of Total Hip and Knee Replacement in the United States.

Authors:  Hilal Maradit Kremers; Dirk R Larson; Cynthia S Crowson; Walter K Kremers; Raynard E Washington; Claudia A Steiner; William A Jiranek; Daniel J Berry
Journal:  J Bone Joint Surg Am       Date:  2015-09-02       Impact factor: 5.284

6.  Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink.

Authors:  D Culliford; J Maskell; A Judge; C Cooper; D Prieto-Alhambra; N K Arden
Journal:  Osteoarthritis Cartilage       Date:  2015-01-09       Impact factor: 6.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.